Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-country, Post Marketing Observational Study of DME Patients With Suboptimal Response to Anti-VEGF Who Are Initiated With Dexamethasone Intravitreal Implant (DEX-I)

NCT05978622 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05978622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05978622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-country, Post Marketing Observational Study of DME Patients With Suboptimal Response to Anti-VEGF Who Are Initiated With Dexamethasone Intravitreal Implant (DEX-I)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
October 30, 2023
Completion date
August 13, 2026
Enrollment
236 (actual)
Sites
54

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema